| Literature DB >> 21447623 |
Abstract
We examined whether the cannabinoid receptor agonist WIN55,212-2 (WIN; 5 µg/side) microinjected into the hippocampus or the amygdala would differentially affect memory processes in a neutral vs. an aversive task. In the aversive contextual fear task, WIN into the basolateral amygdala impaired fear acquisition/consolidation, but not retrieval. In the ventral subiculum (vSub), WIN impaired fear retrieval. In the neutral social discrimination task, WIN into the vSub impaired both acquisition/consolidation and retrieval, whereas in the medial amygdala WIN impaired acquisition. The results suggest that cannabinoid signaling differentially affects memory in a task-, region-, and memory stage-dependent manner.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21447623 DOI: 10.1101/lm.2110511
Source DB: PubMed Journal: Learn Mem ISSN: 1072-0502 Impact factor: 2.460